指南与共识糖尿病

印度自报糖尿病患者中指南推荐糖尿病治疗目标与健康习惯的达成情况(ICMR-INDIAB-13):一项全国横断面研究

Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study.
指南 / 共识 · Lancet Diabetes Endocrinol · 2022-04-21

该研究为ICMR-INDIAB全国横断面调查,纳入5789名20岁及以上自报糖尿病成人,评估血糖、血压、LDL胆固醇及ABC联合目标达成情况。结果示36.3%达成血糖控制、48.8%达成血压控制、41.5%达成LDL控制,仅7.7%达成ABC三项目标。仅16.7%研究人群和36.9%胰岛素使用者报告自我血糖监测。

要点

  • 36.3%达成HbA1c<7.0%目标,48.8%达成血压<140/90 mm Hg目标,41.5%达成LDL<100 mg/dL目标。
  • 仅7.7%自报糖尿病患者同时达成ABC三项目标,地区与邦间存在显著异质性。
  • 仅16.7%研究人群和36.9%胰岛素使用者报告进行自我血糖监测。

核心结论

  • 印度自报糖尿病成人中治疗目标达成与健康行为采纳仍不理想。
  • 研究结果可帮助政府制定政策,优先改善印度糖尿病照护提供与监测。

研究设计与样本

  • 印度医学研究理事会(ICMR)-印度糖尿病(INDIAB)研究为横断面、基于人群的调查,覆盖印度全部30个邦和联邦属地20岁及以上成人。
  • 采用分层多阶段抽样设计,分阶段抽取各邦,农村选村、城市选人口普查区块,并按地理、人口规模和社会经济状况进行三级分层。
  • 2008年10月18日至2020年12月17日共113043人参与(城市33537人,农村79506人),本分析纳入5789名自报糖尿病成人(城市2633人,农村3156人),中位年龄56.1岁(IQR 55.7-56.5)。

主要发现

  • 4834名糖尿病患者中1748人达成良好血糖控制(加权比例36.3%,95%CI 34.7-37.9)。
  • 5698名糖尿病患者中2819人达成血压控制(加权比例48.8%,95%CI 47.2-50.3)。
  • 4886名糖尿病患者中2043人达成LDL胆固醇控制(加权比例41.5%,95%CI 39.9-43.1)。
  • 5297名自报糖尿病患者中仅419人同时达成ABC三项目标(加权比例7.7%),地区与邦间存在显著异质性。
  • 较高教育程度、男性、农村居住及糖尿病病程较短(<10年)与联合ABC目标达成较好相关。

关键数值与推荐

  • 良好血糖控制定义为HbA1c<7.0%(A)。
  • 血压控制定义为<140/90 mm Hg(B)。
  • LDL胆固醇目标定义为<100 mg/dL(C)。
  • ABC控制定义为同时达成血糖、血压和LDL胆固醇三项指标目标的比例。
  • 研究人群951人(加权比例16.7%)报告使用自我血糖监测,胰岛素使用者中227人(加权比例36.9%)报告使用自我血糖监测。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is little information on comprehensive diabetes care comprising glycaemic, lipid, and blood pressure control in India; therefore, we aimed to assess the achievement of treatment targets among adults with self-reported diabetes. METHODS: The Indian Council of Medical Research (ICMR)-India Diabetes (INDIAB) study is a cross-sectional, population-based survey of adults aged 20 years or older in all 30 states and union territories of India. We used a stratified multistage sampling design, sampling states in a phased manner, and selected villages in rural areas and census enumeration blocks in urban areas. We used a three-level stratification method on the basis of geography, population size, and socioeconomic status for each state. For the outcome assessment, good glycaemic control was defined as HbA1c of less than 7·0% (A), blood pressure control was defined as less than 140/90 mm Hg (B), and the LDL cholesterol target was defined as less than 100 mg/dL (C). ABC control was defined as the proportion of individuals meeting glycaemic, blood pressure, and LDL cholesterol targets together. We also performed multiple logistic regression to assess the factors influencing achievement of diabetes treatment targets. FINDINGS: Between Oct 18, 2008, and Dec 17, 2020, 113 043 individuals (33 537 from urban areas and 79 506 from rural areas) participated in the ICMR-INDIAB study. For this analysis, 5789 adults (2633 in urban areas and 3156 in rural areas) with self-reported diabetes were included in the study population. The median age was 56·1 years (IQR 55·7-56·5). Overall, 1748 (weighted proportion 36·3%, 95% CI 34·7-37·9) of 4834 people with diabetes achieved good glycaemic control, 2819 (weighted proportion 48·8%, 47·2-50·3) of 5698 achieved blood pressure control, and 2043 (weighted proportion 41·5%, 39·9-43·1) of 4886 achieved good LDL cholesterol control. Only 419 (weighted proportion 7·7%) of 5297 individuals with self-reported diabetes achieved all three ABC targets, with significant heterogeneity between regions and states. Higher education, male sex, rural residence, and shorter duration of diabetes (<10 years) were associated with better achievement of combined ABC targets. Only 951 (weighted proportion 16·7%) of the study population and 227 (weighted proportion 36·9%) of those on insulin reported using self-monitoring of blood glucose. INTERPRETATION: Achievement of treatment targets and adoption of healthy behaviours remains suboptimal in India. Our results can help governments to adopt policies that prioritise improvement of diabetes care delivery and surveillance in India. FUNDING: Indian Council of Medical Research and Department of Health Research, Ministry of Health and Family Welfare.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Anjana RM, Unnikrishnan R, Deepa M, et al. Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study. Lancet Diabetes Endocrinol. 2022. PMID: 35461575. doi:10.1016/S2213-8587(22)00072-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。